Top Authors

• Most frequent coverage on ZGEN

• 
  SA Editor Miriam Metzinger (531 followers)

  • Jim Cramer's Mad Money Lightning Round, 1/14/08: More PWR to You (Tue, Jan 15)
  • Jim Cramer's Mad Money In-Depth Stock Picks, Oct. 3 (Tue, Oct 3)
  • Jim Cramer's Mad Money Lightning Round Picks, Sept. 22 (Mon, Sep 25)

  More by SA Editor Miriam Metzinger on ZGEN »
• 
  Centient Biotech Investor (10 followers)

  • Biotech Day in Review: Avalon Signs $200 Million Deal with Merck (Thu, Mar 8)
  • Biotech Stock Review: GPC Biotech Completes New Drug Approval (Tue, Feb 20)
  • Biotech Stocks Day In Review: Alfacell Receives Orphan Drug Status For Onconase (Wed, Jan 31)

  More by Centient Biotech Investor on ZGEN »
• 
  The Burrill Report (196 followers)

  • Making and Breaking Biotech Deals (Mon, Dec 14)
  • Biotech's Latest Failed Trials, Missed Targets (Mon, Dec 14)

  More by The Burrill Report on ZGEN »

• Most followed authors on ZGEN

• 
  Mike Havrilla (1924 followers)

  • Top 10 Emerging Biotech Stocks (Mon, Oct 15)

  More by Mike Havrilla on ZGEN »
• 
  Andrew Wilkinson (1153 followers)

  • Tuesday's Options Report: UAUA, Adobe, ZGEN, NLS, KWK, WPZ, Best Buy, GS (Tue, Dec 18)

  More by Andrew Wilkinson on ZGEN »
• 
  Zacks.com (1052 followers)

  • Five Biotech Stocks to Weather a Down Market (Tue, Apr 22)
  • Biotech Stocks: Sector Outlook and Top Picks (Tue, Apr 8)

  More by Zacks.com on ZGEN »

• Newest authors on ZGEN

• 
  Justin M. Hall (672 followers)

  • Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers (Sun, Sep 20)
  • Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up (Fri, Sep 11)

  More by Justin M. Hall on ZGEN »
• 
  The Burrill Report (196 followers)

  • Making and Breaking Biotech Deals (Mon, Dec 14)
  • Biotech's Latest Failed Trials, Missed Targets (Mon, Dec 14)

  More by The Burrill Report on ZGEN »
• 
  Mark Cifra (30 followers)

  • Q1 2009 Biotech Roundup: The Good, the Bad and the Ugly (Thu, Apr 2)

  More by Mark Cifra on ZGEN »

• Most commented on ZGEN

• 
  Justin M. Hall (672 followers)

  • Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers (Sun, Sep 20)
  • Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up (Fri, Sep 11)

  More by Justin M. Hall on ZGEN »
• 
  Mark Cifra (30 followers)

  • Q1 2009 Biotech Roundup: The Good, the Bad and the Ugly (Thu, Apr 2)

  More by Mark Cifra on ZGEN »
• 
  SA Editor Miriam Metzinger (531 followers)

  • Jim Cramer's Mad Money Lightning Round, 1/14/08: More PWR to You (Tue, Jan 15)
  • Jim Cramer's Mad Money In-Depth Stock Picks, Oct. 3 (Tue, Oct 3)
  • Jim Cramer's Mad Money Lightning Round Picks, Sept. 22 (Mon, Sep 25)

  More by SA Editor Miriam Metzinger on ZGEN »